GGrantIndex
← Leaderboards

Mayo Clinic Arizona

Scottsdale, AZ

Compare ↔
$292,791,581
Total funding
230
Grants

Funding over time

peak $41.1M · FY2005–25
$50M$37.5M$25M$12.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$266,584,142 · 216
DOD$22,984,739 · 9
AHRQ$1,680,783 · 2
FDA$1,399,153 · 2
NASA$142,764 · 1

By mechanism

R01$159,385,413 · 97
—$23,127,503 · 10
P50$21,764,888 · 25
U01$15,376,997 · 6
P01$14,522,283 · 12
R37$10,079,085 · 4

Investigators at Mayo Clinic Arizona

Investigator-initiatedAll funding

InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).

Rising Stars

First grant in the last 5 yrs

1Jessica N Lancaster$1,828,8131 gr2Marion Curtis$1,403,0251 gr3Judy Gichoya$814,5382 gr4Robert Ardecky$767,1061 gr5Hakan Ceylan$703,5231 gr6Mohsen Khosravi Maharlooei$457,7071 gr7Mazie Tsang$420,0001 gr8Stephanie Rc Zacharias$40,0001 gr

Emerging Leaders

6–10 yrs in

1Jingwei Xie$7,732,7668 gr2Wuqiang Zhu$6,841,3506 gr3Catherine Daniela Chong$5,263,7952 gr4David G Lott$3,158,5952 gr5Diane Kristen Ehlers$2,264,6531 gr6Elizabeth Carey$1,129,9402 gr7Christopher Staley$975,1752 gr8Patrick M Sexton$752,8461 gr

All-Time

Most funded here, all years

1Hirohito Kita$26,552,39512 gr2Ali Khademhosseini$19,228,81322 gr3Laurence J Miller$18,092,1498 gr4Vijay Prem Singh$10,090,9604 gr5Rahmi Oklu$9,676,7448 gr6Fotini Gounari$8,852,8688 gr7Eduard A. Sergienko$7,975,0288 gr8Jingwei Xie$7,732,7668 gr

Largest grants

A MULTIDISCIPLINARY TRANSLATIONAL APPROACH TO INVESTIGATE THE MECHANISMS, PREDICTORS, AND PREVENTION OF PERSISTENT POST-TRAUMATIC HEADACHE$9,999,820
· FY2019 · Defense Health Agency
Novel genetic modifiers of C9orf72 and Tau toxicity$4,037,235
RF1 · FY2019 · AG
Microglial apoE in neuroinflammation and Alzheimer's disease$4,000,570
RF1 · FY2019 · AG
PHASE 1 CLINICAL TRIAL USING AUTOLOGOUS, MUC1-ACTIVATED T CELLS EXPANDED FROM PERIPHERAL BLOOD IN PATIENTS WITH RELAPSED AND RESISTANT OVARIAN CANCER$3,291,419
· FY2025 · Defense Health Agency
Biomarker Signature to Predict the Persistence of Post-Traumatic Headache$3,152,333
R61 · FY2019 · NS
Mayo Clinic Multiple Myeloma SPORE$2,538,499
P50 · FY2018 · CA
Oncolytic Virotherapy in Hepatocellular Cancer$2,490,000
DP2 · FY2014 · CA
Overcoming Drug Resistance in Multiple Myeloma$2,468,281
U54 · FY2017 · CA
Mayo Clinic Multiple Myeloma SPORE$2,299,999
P50 · FY2017 · CA
Mayo Clinic Multiple Myeloma SPORE$2,224,423
P50 · FY2025 · CA
Mayo Clinic Multiple Myeloma SPORE$2,185,000
P50 · FY2015 · CA
Mayo Clinic Multiple Myeloma SPORE$2,161,999
P50 · FY2016 · CA
Mayo Clinic Multiple Myeloma SPORE$2,120,249
P50 · FY2019 · CA
Molecular Diagnosis, Prognosis, and Therapeutic Targets in Lymphoma$2,117,897
P01 · FY2021 · CA
Molecular Diagnosis, Prognosis, and Therapeutic Targets in Lymphoma$2,112,284
P01 · FY2020 · CA
Mayo Clinic Multiple Myeloma SPORE$2,098,348
P50 · FY2024 · CA
Mayo Clinic Multiple Myeloma SPORE$2,091,215
P50 · FY2021 · CA
Molecular Diagnosis, Prognosis, and Therapeutic Targets in Lymphoma$2,087,361
P01 · FY2018 · CA
Mathematical Oncology Systems Analysis Imaging Center (MOSAIC)$2,086,730
U54 · FY2023 · CA
Mayo Clinic Multiple Myeloma SPORE$2,031,615
P50 · FY2022 · CA